• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Buyouts

Ardian sells Lagarrigue to Naxicap

  • Alessia Argentieri
  • Alessia Argentieri
  • 27 April 2021
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Ardian has sold its majority stake in a French orthopaedic equipment manufacturer Lagarrigue Group to Naxicap Partners.

Naxicap acquired an 80% stake in a deal valuing the business at around €485m, equal to 18x its 2021 expected EBITDA, according to French publication Capital Finance.

Ixo Private Equity is understood to have sold its minority stake, which the firm had held since 2016.

Lagarrigue

  • DEAL:

    SBO

  • LOCATION:

    Toulouse

  • SECTOR:

    Medical equipment

  • FOUNDED:

    1976

  • TURNOVER:

    €91.6m (2019)

  • STAFF:

    832

Ardian put the company on the market in February 2021, when it hired Edmond de Rothschild to advise on the sale. Several private equity firms showed early interest for the business, including Naxicap, IK Investment Partners, Eurazeo, CNP, Cobepa and HDL, according to Unquote sister publication Mergermarket.

At the beginning of April, it was reported by the French press that Cobepa, IK and Naxicap were the last contenders in the auction, which valued the company at around €450m, based on expected EBITDA of €25m for 2021.

The sale to Naxicap ends a five-year holding period for Ardian, which acquired a majority stake in Lagarrigue from Azulis Capital. As part of the deal, Lagarrigue's management increased its holding in the business and Ixo retained a minority stake, while BNP Paribas, Galia Gestion and Acto Mezz exited their investment alongside Azulis. Ardian invested in the company via its €1bn fund Ardian Expansion IV.

Under Ardian's ownership, Lagarrigue consolidated its market position, expanded internationally and completed 25 add-on acquisitions. The company entered new markets, including Spain and North America, and recorded average sales growth of 20% per year.

Previous funding
In 2008, Ixo backed the OBO of Lagarrigue, investing from its FCPR Icso 2 and FIP Aquitaine Pyrénées Languedoc funds. Leverage represented around half of the undisclosed deal value.

Azulis acquired an 80% stake in the secondary buyout of Lagarrigue from Ixo in May 2011. Azulis invested via its FCPR MMF IV vehicle, while Ixo divested its minority stake, making 2.5x its initial investment for a 38% IRR. Ixo reinvested as a minority shareholder in the buyout alongside BNP Paribas Développement and Galia Gestion.

CEO Alain Montean and three other members of the management team acquired the remainder of the shares. Crédit Agricole and LCL arranged a senior debt package to fund the acquisition, understood to be worth around 30% of the enterprise value. Acto Mezz provided mezzanine financing.

Company
Established in 1976 and headquartered in Toulouse, Lagarrigue is a specialist in designing and manufacturing orthopaedic prosthetics for patients suffering from permanent or temporary disability.

The company has an in-house team of ortho-prosthetists. Custom-made products account for 95% of the company's business.

Employing 832 staff, the company generated turnover of €91.6m in 2019.

People
Ardian Expansion – Marie Arnaud-Battandier (managing director).
Naxicap Partners – Luc Bertholat (member of the management board).
Lagarrigue – Alain Montean (CEO); Jean-Pierre Mahé (chair).

Advisers
Acquirer – Indefi (financial due diligence); McDermott Will & Emery (legal).
Vendor – Edmond de Rothschild (corporate finance); BCG (commercial due diligence); Eight Advisory (financial due diligence); Weil Gotshal & Manges (legal).

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Buyouts
  • Exits
  • Healthcare
  • France
  • Ardian (formerly Axa PE)
  • Naxicap
  • France
  • McDermott Will & Emery

More on Buyouts

Clinical trials and biotechnology
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • Buyouts
  • 04 September 2023
EMEA Public to Private M&A
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • Investments
  • 04 September 2023
HR software solutions providers
Main Capital’s Assessio to be sold to Pollen Street

Recruitment software company tripled in revenue under Main Capital’s ownership

  • Buyouts
  • 25 August 2023
Ice cream
Exponent divests ‘significant' stake in Meadow to Canadian investor

Since 2018, GP has diversified food ingredients company's focus beyond commodity dairy

  • Exits
  • 22 August 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013